Private Trust Company’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-135
Closed -$3.46K – 2564
2025
Q2
$3.46K Buy
135
+33
+32% +$966 ﹤0.01% 2164
2025
Q1
$3.73K Hold
102
– – ﹤0.01% 2133
2024
Q4
$3.13K Hold
102
– – ﹤0.01% 2107
2024
Q3
$3.84K Hold
102
– – ﹤0.01% 2035
2024
Q2
$4.04K Sell
102
-13
-11% -$421 ﹤0.01% 2001
2024
Q1
$3.87K Hold
115
– – ﹤0.01% 2001
2023
Q4
$3.83K Hold
115
– – ﹤0.01% 2013
2023
Q3
$3.61K Hold
115
– – ﹤0.01% 1973
2023
Q2
$3.64K Hold
115
– – ﹤0.01% 1967
2023
Q1
$3.8K Sell
115
-35
-23% -$1.15K ﹤0.01% 1938
2022
Q4
$5K Sell
150
-40
-21% -$1.36K ﹤0.01% 1775
2022
Q3
$7K Hold
190
– – ﹤0.01% 1555
2022
Q2
$8K Buy
+190
New +$9.23K ﹤0.01% 1566

Other funds holding ATEX

Private Trust Company's ATEX Position: Q3 2025 in Review

Private Trust Company sold out of Anterix (ATEX) in Q3 2025, closing a stake of 135 shares — an estimated $3.46K sold.

Private Trust Company first reported a position in ATEX in Q2 2022 and held it in 13 quarters. The position peaked at $8K in Q2 2022. 111 funds tracked by Wall St. Rank hold ATEX as of Q3 2025.

  • Private Trust Company reported no remaining Anterix position as of Q3 2025 after selling out during the quarter.
  • Private Trust Company sold 135 Anterix shares in Q3 2025, an estimated $3.46K.
  • Private Trust Company first reported a position in Anterix in Q2 2022 and held it in 13 quarters.
  • Private Trust Company's Anterix position peaked at $8K in Q2 2022.
  • 111 funds tracked by Wall St. Rank held Anterix as of Q3 2025.

Based on Private Trust Company's 13F filing for Q3 2025, filed 15 Oct 2025.